Clinical Trial Update: OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277 [Phase 3]

View source ↗

Summary

A Phase 3 open-label trial evaluating long-term effects of DiaPep277 in Type 1 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DiaPep277 (DiaPep277)

Snippet

Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes | Phase 3 | Status: TERMINATED